| Polyphenol and tannin nutraceuticals and their metabolites: How the human gut microbiota influences their properties M Fabbrini, F D’Amico, M Barone, G Conti, M Mengoli, P Brigidi, S Turroni Biomolecules 12 (7), 875, 2022 | 28 | 2022 |
| Pharmacomicrobiomics in anticancer therapies: why the gut microbiota should be pointed out G Conti, F D’Amico, M Fabbrini, P Brigidi, M Barone, S Turroni Genes 14 (1), 55, 2022 | 9 | 2022 |
| Gut microbiota resilience and recovery after anticancer chemotherapy S Roggiani, M Mengoli, G Conti, M Fabbrini, P Brigidi, M Barone, ... Microbiome Research Reports 2 (3), 2023 | 3 | 2023 |
| A comparative absorption study of sucrosomial® orodispersible vitamin D3 supplementation vs. a reference chewable tablet and soft gel capsule vitamin D3 in improving … A Bano, S Abrar, E Brilli, G Tarantino, AA Bugti, M Fabbrini, G Conti, ... Frontiers in Nutrition 10, 2023 | 1 | 2023 |
| A comparative absorption study of sucrosomial® orodispersible vitamin D3 supplementation vs. a reference chewable tablet and soft gel capsule vitamin D3 in … A Bano, S Abrar, E Brilli, G Tarantino, AA Bugti, M Fabbrini, G Conti, ... Frontiers in Nutrition 10, 1221685, 2023 | | 2023 |
| Interaction between gut microbiome and immune checkpoint inhibitor treatment in lymphoma patients: Final results of the MICRO‐LINF study B Casadei, L Argnani, S Guadagnuolo, L Nanni, C Pellegrini, A Broccoli, ... Hematological Oncology 41, 310-311, 2023 | | 2023 |
| Gut microbiome in DLBCL patients undergoing first‐line R‐CHOP regimen—The Oncopassport Study V Stefoni, L Argnani, B Casadei, G Musuraca, L Nanni, C Pellegrini, ... Hematological Oncology 41, 283-285, 2023 | | 2023 |
| Microbiota-gut-brain axis and ketogenic diet: how close are we to tackling epilepsy? M Mengoli, G Conti, M Fabbrini, M Candela, P Brigidi, S Turroni, ... Microbiome Research Reports 2 (4), 2023 | | 2023 |
| Bifidobacterium in anticancer immunochemotherapy: friend or foe? G Procaccianti, S Roggiani, G Conti, P Brigidi, S Turroni, F D’Amico Microbiome Research Reports 2 (3), 2023 | | 2023 |
| Design of New Personalized Therapeutic Approaches for Diffuse Large B-Cell Lymphoma through Gut Microbiome Profiling L Nanni, G Musuraca, A Morigi, V Stefoni, M Barone, G Conti, M Fabbrini, ... Blood 140 (Supplement 1), 4961-4963, 2022 | | 2022 |
